Furthermore, miR-34a plays a significant role in making pancreatic cancer cells more responsive to chemotherapy and radiotherapy, ultimately leading to the suppression of cancer growth and the induction of cell apoptosis by inhibiting the expression of Bcl-2 and Notch signaling pathways [143]. This evidence concerns the gene BCL2 and familial pancreatic carcinoma.